Published in Ophthalmic Res on January 01, 1992
Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest (1994) 1.09
Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. Virchows Arch (2005) 0.97
Glycobiology of ocular angiogenesis. Glycobiology (2014) 0.76
Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev (1996) 1.82
The mitogenic signaling pathway of fibroblast growth factor is not mediated through polyphosphoinositide hydrolysis and protein kinase C activation in hamster fibroblasts. J Biol Chem (1986) 1.46
The use of acetone precipitation in the isolation of ribosomal proteins. Eur J Biochem (1976) 1.38
Modulation of cranial bone healing with a heparin-like dextran derivative. J Craniofac Surg (1996) 1.38
Acidic fibroblast growth factor is a modulator of epithelial plasticity in a rat bladder carcinoma cell line. Proc Natl Acad Sci U S A (1990) 1.37
gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. Proc Natl Acad Sci U S A (1982) 1.27
Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci U S A (1989) 1.27
Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III. Biochimie (1985) 1.24
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res (1991) 1.19
The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun (2000) 1.14
Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor. J Neurosci Res (1982) 1.06
Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes. Exp Cell Res (1987) 1.05
Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun (1991) 1.04
Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors (1994) 1.01
Synchrotron radiation FTIR imaging in minutes: a first step towards real-time cell imaging. Anal Bioanal Chem (2010) 1.00
Birdshot retinochoroidopathy: measurement of the posterior fundus spots and macular edema using a retinal thickness analyzer, before and after treatment. Eur J Ophthalmol (2001) 0.98
Evidence and characterization of the receptor to eye-derived growth factor I, the retinal form of basic fibroblast growth factor, on bovine epithelial lens cells. Proc Natl Acad Sci U S A (1986) 0.95
[Bilateral central retinal vein occlusion and circulating anticoagulant]. J Fr Ophtalmol (1995) 0.93
[Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]. J Fr Ophtalmol (2008) 0.92
Visual function and course of basal laminar drusen combined with vitelliform macular detachment. Br J Ophthalmol (1994) 0.92
Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem (1989) 0.91
Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate (1999) 0.91
Early and late mitogenic events induced by FGF on bovine epithelial lens cells are not triggered by hydrolysis of polyphosphoinositides. Biochem Biophys Res Commun (1987) 0.91
Interactions of FGFs with target cells. Prog Growth Factor Res (1992) 0.90
Eye-derived growth factor isolated from bovine retina and used for epidermal wound healing in vivo. J Invest Dermatol (1986) 0.90
Is there a ubiquitous growth factor in the eye? Proliferation induced in different cell types by eye-derived growth factors. Differentiation (1981) 0.90
Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res (1992) 0.90
Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem (2000) 0.89
Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol (1992) 0.89
Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A (2009) 0.89
Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol (1995) 0.88
Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol (2003) 0.88
Modulation of the shape of epithelial lens cells in vitro directed by a retinal extract factor. A model of interconversions and the role of actin filaments and fibronectin. Differentiation (1981) 0.87
Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res (1999) 0.87
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A. BMC Med (2010) 0.86
Evidence for FGF-like growth factor in adult bovine retina: analogies with EDGF I. Biochem Biophys Res Commun (1986) 0.86
RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin. J Biomed Mater Res A (2007) 0.86
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol (1993) 0.86
Increased red blood cell aggregation in retinal vein occlusion. Br J Haematol (1990) 0.85
[Intravitreous injection: retrospective study on 2028 injections and their side effects]. J Fr Ophtalmol (2008) 0.85
Identification of neighbouring proteins in Escherichia coli 30 S ribosome subunits. J Mol Biol (1977) 0.84
Close proximity of Escherichia coli 50 S subunit proteins L7/L12 and L10 and L11. J Mol Biol (1976) 0.84
Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol (Noisy-le-grand) (1998) 0.84
A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle. FASEB J (1999) 0.84
Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage. J Biomed Mater Res (1996) 0.83
[Parry-Romberg progressive facial hemiatrophy and localized scleroderma. Nosologic and pathogenic problems]. J Fr Ophtalmol (1989) 0.83
Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. Eur J Biochem (1998) 0.83
[Retinal vein occlusion and lipoprotein (a)]. J Fr Ophtalmol (1998) 0.83
Gamma heavy chain disease in man: translation and partial purification of mRNA coding for the deleted protein. Proc Natl Acad Sci U S A (1978) 0.83
Enhanced MYCN oncogene expression in human neuroblastoma cells is associated with altered FGF receptor expression and cellular growth response to basic FGF. Biochem Biophys Res Commun (1991) 0.83
[Choroidal neovascularization as a complication following laser treatment of central serous chorioretinopathy]. J Fr Ophtalmol (2001) 0.83
[Occlusion of the central retinal vein with occlusion of a cilioretinal artery: apropos of 7 cases]. J Fr Ophtalmol (1987) 0.82
FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int J Biol Macromol (1996) 0.82
Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut (2004) 0.82
[Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion]. Bull Soc Ophtalmol Fr (1989) 0.82
A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. FASEB J (2003) 0.82
Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res (1984) 0.82
Biochemical comparative studies between eye- and brain-derived growth factors. Biochimie (1987) 0.82
Heparan-like molecules induce the repair of skull defects. Bone (1995) 0.82
RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats. Growth Factors (1998) 0.82
[Vitrectomy-laser-gas for treating optic disk pits complicated by serous macular detachment]. J Fr Ophtalmol (1996) 0.82
Differential expression of FGF receptors and of myogenic regulatory factors in primary cultures of satellite cells originating from fast (EDL) and slow (Soleus) twitch rat muscles. Cell Mol Biol (Noisy-le-grand) (2000) 0.81
The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. J Biol Chem (2001) 0.81
RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. J Fr Ophtalmol (2013) 0.81
[Study of internal limiting membrane peeling in stage-3 and -4 idiopathic macular hole surgery]. J Fr Ophtalmol (2002) 0.81
The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells. Cell Mol Biol (Noisy-le-grand) (2001) 0.81
Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells. Oncogene (1999) 0.81
Identification of neighbouring proteins in the 30 S ribosomes of E. coli. FEBS Lett (1975) 0.81
Identification of neighbouring proteins in E. coli 50S ribosomes. FEBS Lett (1975) 0.81
Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: evidence for multiple autocrine growth factors. Int J Cancer (1992) 0.80
Heparan mimetic regulates collagen expression and TGF-beta1 distribution in gamma-irradiated human intestinal smooth muscle cells. FASEB J (2001) 0.80
Fibroblast growth factor receptors participate in the control of mitogen-activated protein kinase activity during nerve growth factor-induced neuronal differentiation of PC12 cells. J Biol Chem (1999) 0.80
A highly reliable and sensitive assay for the purification of cellular growth factors. Cell Mol Biol (1984) 0.80
Proliferating satellite cells express acidic fibroblast growth factor during in vitro myogenesis. Dev Biol (1990) 0.80
Bioactive functionalized polymer of malic acid for bone repair and muscle regeneration. J Biomater Sci Polym Ed (2000) 0.80
Development and testing of radio and enzyme immunoassays for acidic fibroblast growth factor (aFGF). Anal Biochem (1988) 0.80
Clinical evaluation of the use of infracyanine green staining for internal limiting membrane peeling in epimacular membrane surgery. Eur J Ophthalmol (2008) 0.80
Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta1. Matrix Biol (2001) 0.80
In vivo and in vitro studies of angiogenin--a potent angiogenic factor. Blood Coagul Fibrinolysis (1990) 0.80
Transmural endothelialization of vascular prostheses is regulated in vitro by Fibroblast Growth Factor 2 and heparan-like molecule. Int J Artif Organs (1997) 0.80
Glycosaminoglycans promote HARP/PTN dimerization. Biochem Biophys Res Commun (1999) 0.80
Mesoglycan and sulodexide act as stabilizers and protectors of fibroblast growth factors (FGFs). Growth Factors (1994) 0.79
Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic. J Biomed Mater Res A (2006) 0.79
The effect of an eye derived growth factor (EDGF) on corneal epithelial regeneration. Exp Eye Res (1982) 0.79
Kinetic study of early regenerative effects of RGTA11, a heparan sulfate mimetic, in rat craniotomy defects. Calcif Tissue Int (2004) 0.79
Internalization and limited processing of basic fibroblast growth factor on Chinese hamster lung fibroblasts. Growth Factors (1989) 0.79
Interaction between rat alpha 1 fetoprotein and fluorescent derivatives of estrone in relation to the position and type of the fluorescent label. J Steroid Biochem (1983) 0.79
Presence of basic fibroblast growth factor receptors in bovine brain membranes. J Biol Chem (1988) 0.79
Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic. Cell Death Differ (2009) 0.79
Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland. J Histochem Cytochem (1997) 0.79
Upregulation of the angiogenic factor heparin affin regulatory peptide by progesterone in rat uterus. J Endocrinol (1998) 0.79